Back to Journals » Nutrition and Dietary Supplements » Volume 2

Role of grape seed polyphenols in Alzheimer’s disease neuropathology

Authors Pasinetti G, Ho L

Published 17 August 2010 Volume 2010:2 Pages 97—103

DOI https://doi.org/10.2147/NDS.S6898

Review by Single-blind

Peer reviewer comments 3


Giulio Maria Pasinetti1,2, Lap Ho1

1Department of Neurology, Mount Sinai School of Medicine, New York; 2Geriatric Research, Education and Clinical Center, James J Peters Veteran Affairs Medical Center, Bronx, New York, USA

Abstract: Alzheimer’s disease (AD) is an age-related neurodegenerative condition ­characterized by a progressive decline in cognitive function. AD affects approximately five million people in the US, creating a devastating financial burden on health care costs and an emotional ­burden on caregivers. To date, there is no cure for AD, so researchers are continually exploring novel ­avenues for the prevention and treatment of this condition. In this article, we present some ­findings from our laboratory and those of others on the potential benefits of a grape seed ­polyphenolic extract (GSPE) for the prevention and treatment of AD, including its c­hemical composition, bioactivity, bioavailability, safety, and tolerability, and the mechanisms by which it interferes with AD pathogenesis. Findings presented in this review article support the ­development of GSPE as a preventative and/or therapeutic agent in AD.

Keywords: alzheimer’s disease, neurodegeneration, polyphenols

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]